As with miR-1251-5p, the area under the ROC curve analysis indicated that NPTX2 could predict OS in ccRCC patients (0.691 at 1 year, 0.655 at 3 years, and 0.680 at 5 years), as depicted in Figure 2(d). The gene discussed is NPTX2; the disease is nonpapillary renal cell carcinoma.